These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 30285510

  • 1. Relationship between the NF-κB1-94ins/del ATTG locus polymorphism and risk of hypertension in the Chinese Han population.
    Chen J, Ge D, Xiong Y.
    Clin Exp Hypertens; 2019; 41(6):577-582. PubMed ID: 30285510
    [Abstract] [Full Text] [Related]

  • 2. Meta-analysis of studies on the association between the NF-κB1-94ins/del ATTG promoter polymorphism and cancer.
    Nian X, Zhang W, Li L, Sun Y, Sun E, Han R.
    Tumour Biol; 2014 Dec; 35(12):11921-31. PubMed ID: 25190017
    [Abstract] [Full Text] [Related]

  • 3. The functional 4-bp insertion/deletion ATTG polymorphism in the promoter region of NF-KB1 reduces the risk of BC.
    Eskandari-Nasab E, Hashemi M, Ebrahimi M, Amininia S.
    Cancer Biomark; 2016 Dec; 16(1):109-15. PubMed ID: 26835711
    [Abstract] [Full Text] [Related]

  • 4. NFKB1 -94ins/del ATTG polymorphism increases osteosarcoma risk in a Chinese Han population.
    Li X, Zhang C, Qiao W, Zhou X, Sun M.
    Int J Clin Exp Med; 2015 Dec; 8(1):1420-3. PubMed ID: 25785149
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish population.
    Koc A, Batar B, Celik O, Onaran I, Tasan E, Sultuybek GK.
    Immunobiology; 2014 Jul; 219(7):531-6. PubMed ID: 24703107
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The relationship between functional promoter -94 ins/del ATTG polymorphism in NF-κ B1 gene and the risk of urinary cancer.
    Li X, Gao Y, Zhou H, Xu W, Li P, Zhou J, Xu T, Yu B, Xu Z, Zou Q, Yin C, Cai H, Shen W.
    Cancer Biomark; 2016 Jul; 16(1):11-7. PubMed ID: 26484607
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Relation of MBL ExonI 54 and NFκB1-94ins/del ATTG Polymorphism with Fever during Neutropenia in Patients with Acute Leukaemia after Chemotherapy].
    Xu WN, Jiang ZJ, Li YH, Xiao HW, Gao Y, Pang Y, Ouyang L, Liu ZH, Zhang LQ, Wang Y, Xiao Y.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1258-64. PubMed ID: 26524019
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An updated meta-analysis of 37 case-control studies on the association between NFKB1 -94ins/del ATTG promoter polymorphism and cancer susceptibility.
    Luo YQ, Wang D, Gong T, Zhu J.
    Oncotarget; 2016 Sep 06; 7(36):58659-58670. PubMed ID: 27463002
    [Abstract] [Full Text] [Related]

  • 15. Relationship between NF-κB1 -94 ins/del ATTG polymorphism and susceptibility of multiple sclerosis in Iranian MS patients.
    Zahednasab H, Mesbah-Namin SA, Sahraian MA, Balood M, Doosti R.
    Neurosci Lett; 2013 Jun 17; 545():46-9. PubMed ID: 23618653
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.